Table 3 Relationship between systemic inflammation response index and clinical features of upper tract urothelial carcinoma patients

Sex (%)

0.669

 Male

43

28 (65.1%)

15 (34.9%)

 Female

38

23 (60.5%)

15 (69.5%)

Age (years, %)

0.312

 70

49

33 (67.3%)

16 (32.7%)

 < 70

32

18 (56.3%)

14 (43.7%)

Body mass index (BMI, %)

0.567

 ≥ 24.0

33

22 (66.7%)

11 (33.3%)

 < 24.0

48

29 (60.4%)

19 (39.6%)

Pathological grading (%)

0.002

 Low-grade

18

1 (5.6%)

17 (94.4%)

 High-grade

63

29 (46.0%)

34 (54.0%)

Tumor type (%)

0.000

 Papillary tumor

38

6 (13.2%)

33 (86.8%)

 Invasive tumor

43

18 (41.9%)

25 (58.1%)

Clinical stages (%)

0.000

 T1

20

19 (95.0%)

1 (5.0%)

 T2

16

13 (81.3%)

3 (18.7%)

 T3

42

19 (45.2%)

23 (54.8%)

 T4

3

0 (0.0%)

3 (100.0%)